Arçelik A.Ş. developed BeyondCare®, a mobile ECG monitoring system offering great convenience to patients. The device allows easy follow-up and analysis of vital data such as cardiac rhythm, activity, respiration and body temperature. Oğuzhan Öztürk, Arçelik A.Ş. Chief Production & Technology Officer said: “We’ve combined our digital capabilities and our know-how regarding the Internet of Things to develop an easy-to-use health product. Our aim is to help people lead healthy lives and to create value for them.”
Arçelik A.Ş., has now launched BeyondCare®, its next-generation smart tracking solution. BeyondCare® is a mobile ECG monitoring system that allows remote monitoring of vital data such as cardiac rhythm, respiration, activity and body temperature. Weighing only 14 grams, this water-resistant cordless product is worn over the heart but does not affect patients’ daily lives. With BeyondCare®, patients can be monitored by a doctor without leaving home. Doctors can analyse a patient’s status using reports from the data obtained. BeyondCare® provides simplicity for patients and healthcare professionals.
In his speech at the product launch during Turkey Innovation and Entrepreneurship Week (6-9 December), Oğuzhan Öztürk, Chief Production & Technology Officer at Arçelik A.Ş., said: “What underlies the success of Arçelik A.Ş., which has been developing leading technologies worldwide, is the company’s R&D experience of 26 years as well as its inherent innovation skills. Today, as innovation reshapes industries, we are building our business models accordingly. One of the areas that thrills us is healthy living. We’ve combined our digital capabilities and our know-how regarding the Internet of Things to develop an easy-to-use health product. Human life is of paramount importance. Our aim is to help people lead healthy lives and to create value for them.”
Highlighting the fact that clinical studies for BeyondCare® were carried out at Koç University Hospital and that the device has been approved by the US Food and Drug Administration, Öztürk said that patients will lead comfortable daily lives thanks to this lightweight and easy-to-use product.
Öztürk drew attention to the growing need in this area due to ageing populations and increasing average life expectancy. “Cardiovascular diseases are the leading cause of death worldwide”, said Öztürk. “There are nearly 3.5 million people with coronary heart disease in our country, with an additional 140,000 people every year. According to the World Health Organization, it is possible to prevent three out of every four cases by taking measures. And we, as a company focusing on people, want to understand customer needs and use our R&D and power of innovation to offer useful services in the area of health, which is one of our top priorities. The key to success for us is to know the market and to be able to turn technological capabilities into products and services that benefit users. Our next-generation products and services, which will be based on the data we acquire through the digital health infrastructure offered by BeyondCare® Mobile ECG Monitoring Systems, will make the lives of patients and doctors easier.”
Features of BeyondCare® Mobile ECG Monitoring Systems
Apart from the level of comfort it offers with its distinctive small form factor and water-resistant design, BeyondCare® also has a battery life that allows doctors to monitor patients for up to seven days.
BeyondCare® speeds up diagnoses (thus reducing health expenses) thanks to its long tracking time, which is crucial for detecting heart arrhythmia.
The data obtained from measurements are processed with smart algorithms on a cloud-based platform to obtain analyses of patients’ heart health, physical condition and sleep patterns. The results of these measurements and analyses are stored on the platform to allow for retrospective monitoring.
Measurements performed using the BeyondCare® Mobile Monitoring Device can also be tracked in real time thanks to the instant data monitoring feature. Healthcare professionals can track a patient’s vital data anywhere.
Clinical trials carried out at Koç University Hospital in collaboration with the Koç University Research Centre for Translational Medicine revealed that the results obtained from the measurements performed with the BeyondCare® Mobile Monitoring Device are equal to those obtained by a Holter monitor.
BeyondCare® has been approved by the US Food and Drug Administration, an important authority in the field of healthcare.